• Mission

    Spring Bank is devoted to pioneering its revolutionary SMNH chemistry platform to discover and develop a new generation of medicines to improve the lives of patients worldwide.
    About Us
  • Pipeline

    Our internally-developed pipeline focuses on the STING pathway and includes our STING agonist, STING antagonist, and STING agonist ADC programs.
    Learn More
  • Science

    Our proprietary small molecule nucleic acid hybrids (SMNH) chemistry platform produces a class of compounds designed to selectively target and modulate the activity of specific proteins implicated in various disease states.
    Details
  • Latest News